Abstract:Psoriasis is a chronic inflammatory cutaneous disorder of multifactorial etiology, influenced by both genetic and environmental factors such as infection (Nestle et al., 2009Nestle F.O. Kaplan D.H. Barker J. Psoriasis.N Engl J Med. 2009; 361: 496-509Crossref PubMed Scopus (1950) Google Scholar), especially bacterial infection (England et al., 1997England R.J. Strachan D.R. Knight L.C. Streptococcal tonsillitis and its association with psoriasis: a review.Clin Otolaryngol Allied Sci. 1997; 22: 532-535Crossref PubMed Scopus (17) Google Scholar; Brown et al., 2000Brown D.W. Baker B.S. Ovigne J.M. et al.Skin CD4+ T cells produce interferon-gamma in vitro in response to streptococcal antigens in chronic plaque psoriasis.J Invest Dermatol. 2000; 114: 576-580Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar; Gudjonsson et al., 2003Gudjonsson J.E. Thorarinsson A.M. Sigurgeirsson B. et al.Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study.Br J Dermatol. 2003; 149: 530-534Crossref PubMed Scopus (160) Google Scholar; El-Rachkidy et al., 2007El-Rachkidy R.G. Hales J.M. Freestone P.P. et al.Increased blood levels of IgG reactive with secreted Streptococcus pyogenes proteins in chronic plaque psoriasis.J Invest Dermatol. 2007; 127: 1337-1342Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar). Specifically, streptococcal DNA was found to be involved in psoriasis development. The proliferation of peripheral blood mononuclear cells (PBMCs), activation of T cells, and interferon-a (IFN-a) secretion by PBMCs were attenuated after stimulation of non-NASA (non-nucleic acid streptococcal antigen, non-NASA). The attenuated T-cell activation and IFN-a secretion in psoriatic patients could be reconstituted when stimulated by non-NASA combined with synthetic CpG-A (CpG-A is synthetic ODN containing CpG motifs and activate pDC; Cai et al., 2009Cai Y.H. Lu Z.Y. Shi R.F. et al.Enhanced proliferation and activation of peripheral blood mononuclear cells in patients with psoriasis vulgaris mediated by streptococcal antigen with bacterial DNA.J Invest Dermatol. 2009; 129: 2653-2660Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar). At the same time, a single-nucleotide polymorphism (SNP) rs1713239 ((interleukin (IL)-20)-1723 C->G) was found to be associated with psoriatic patients, especially those patients triggered or acerbated by upper respiratory tract infection (Chen et al., 2011Chen X.Y. Jin L.W. Chen Y.W. et al.The association between the IL-20-1723C—>G allele on the 1q chromosome and psoriasis triggered or exacerbated by an upper respiratory tract infection in the Chinese Han population.Dermatology. 2011; 222: 24-30Crossref PubMed Scopus (9) Google Scholar). We recently found potential synergy between this SNP rs1713239 and CpG-A or IL-1β in regulating the transcriptional activity of the IL-20 promoter, which enhances IL-20 expression further. We found that patients carrying the G allele produced more IL-20 upon CpG-A or IL-1β stimulation, compared with the ones carrying the C allele (Wang et al., 2013Wang L.Q. Li K.J. Xu Q.N. et al.Potential synergy between SNP and CpG-A or IL-1β in regulating transcriptional activity of IL-20 promoter.J Invest Dermatol. 2013; 134: 389-395Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar). In the process of investigating the pathogenesis of psoriasis, we found that dermal γδ T cells rather than Th17 cells was the main source of IL-17 in the skin upon IL-23 stimulation, and this process needs IL-1β. IL-23 was produced by dendritic cells and macrophages upon stimulation by the microbial products (Cai et al., 2011Cai Y.H. Shen X.Y. Ding C.L. et al.Pivotal Role of Dermal IL-17-Producing gd T Cells in Skin Inflammation.Immunity. 2011; 35: 596-610Abstract Full Text Full Text PDF PubMed Scopus (607) Google Scholar). Based on these findings, we proposed skin targeting therapy. The treatment aims at protecting the integrity of the epidermis in order to minimize disease exacerbation, which results from the activation of subcutaneous inflammatory cells due to skin damage. Our research found that by reinforcing barrier protection, psoriasis patients had significant increase in their normal and lesional skin electrical capacitance, decrease in lesion transepidermal water loss, and psoriasis area and severity index scores. More importantly, the relapse rate in these patients was lower than in controls. Skin electrical capacitance, decrease in lesional transepidermal water loss, and psoriasis area and severity index score decreases soon after topical steroid treatment, but the index returned to the baseline after long-term usage of steroid. The authors state no conflict of interest. This work was supported by the National Natural Science Foundation of China (30872278 and 81171500) and the Science and Technology Commission Foundation of Shanghai, 2011 (11JC1407500). We are most grateful to all the patients who have willingly participated in this study.

The Benefit of the Optimized Formula of Yinxieling in Psoriasis Vulgaris via Regulation on Autophagy Based on microRNA Expression Profile and Network Pharmacology Analysis

Anti-Angiogenic Efficacy of PSORI-CM02 and the Associated Mechanism in Psoriasis In Vitro and In Vivo

Infection: an Important Role in the Pathogenesis of Psoriasis

Integrating network pharmacology, molecular docking, and experimental validation to reveal the mechanism of Radix Rehmanniae in psoriasis

PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice

Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments

Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial

Network Pharmacology Analysis of Traditional Chinese Medicine for Treating Psoriasis: Identifying Core Components, Mechanisms, and Dosing Patterns

Comprehensive Analysis to Identify Rh Family C Glycoprotein (RHCG) as the Causative Gene for Psoriasis and Search for Alternative Treatment Modalities

Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Mouse Model via Reducing Macrophage Infiltration and Inhibiting Glycolysis

Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice

Effect of governor vessel moxibustion (GVM) therapy with mild to moderate psoriasis: A randomized clinical trial

Anti-psoriasis molecular targets and active components discovery of Optimized Yinxieling Formula via affinity-purified strategy

Topical Delivery of microRNA-125b by Framework Nucleic Acids for Psoriasis Treatment

Uncovering the mechanism of Jueyin granules in the treatment of psoriasis using network pharmacology

Qinzhuliangxue mixture alleviates psoriasis-like skin lesions via inhibiting the IL6/STAT3 axis

Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis

Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis

Effect of Azelaic Acid on Psoriasis Progression Investigated Based on Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (AKT) Signaling Pathway

Pathogenesis, Multi-Omics Research, and Clinical Treatment of Psoriasis.

[Clinical study of modified Yiyi Baijiang Decoction on psoriasis vulgaris due to dampness-heat accumulation]